A Study of DS-1001b in Patients With Chemotherapy- and Radiotherapy-Naive IDH1 Mutated WHO Grade II Glioma
Clinical trial NCT04458272 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04458272
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-08
- Primary completion
- 2023-03-10
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.